Regions Financial Corp’s Blueprint Medicines BPMC Stock Holding History

Regions Financial Corp’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-150	Closed	-$12K	–	946
2019 Q1	$12K	Hold	150	–	–	﹤0.01%	1482
2018 Q4	$8K	Hold	150	–	–	﹤0.01%	1553
2018 Q3	$12K	Hold	150	–	–	﹤0.01%	1579
2018 Q2	$10K	Hold	150	–	–	﹤0.01%	1638
2018 Q1	$14K	Hold	150	–	–	﹤0.01%	1548
2017 Q4	$11K	Buy	+150	New	+$10.6K	﹤0.01%	1643

Other funds holding BPMC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Regions Financial Corp's BPMC Position: Q2 2019 in Review

Regions Financial Corp sold out of Blueprint Medicines (BPMC) in Q2 2019, closing a stake of 150 shares — an estimated $12K sold.

Regions Financial Corp first reported a position in BPMC in Q4 2017 and held it in 6 quarters. The position peaked at $14K in Q1 2018. 220 funds tracked by Wall St. Rank hold BPMC as of Q2 2019.

Regions Financial Corp reported no remaining Blueprint Medicines position as of Q2 2019 after selling out during the quarter.
Regions Financial Corp sold 150 Blueprint Medicines shares in Q2 2019, an estimated $12K.
Regions Financial Corp first reported a position in Blueprint Medicines in Q4 2017 and held it in 6 quarters.
Regions Financial Corp's Blueprint Medicines position peaked at $14K in Q1 2018.
220 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2019.

Based on Regions Financial Corp's 13F filing for Q2 2019, filed 19 Jul 2019.